Jade Biosciences, Inc. (JBIO)

NCM – Real Time Price. Currency in USD

23.21

+0.86 (3.85%)

Market open: Aug 12, 2026, 11:58 AM EDT

22.35

0.00 (0.00%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

Cost of goods sold

-26K

-282K

-96K

-68K

Gross Profit

-26K

-282K

-96K

-68K

Operating expenses (excl. COGS)

-114M

-74M

-81M

-53M

Operating Income

-114M

-75M

-81M

-53M

Non-operating income, total

-14M

Pretax income

-127M

-70M

-75M

-51M

Equity in earnings

Taxes

-58K

-55K

-56K

-25K

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-127M

-70M

-76M

-52M

Discontinued operations

Net income

-127M

-70M

-76M

-52M

Dilution adjustment

Preferred dividends

Jade Biosciences, Inc. (JBIO)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Jade Biosciences, Inc. (JBIO)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Jade Biosciences, Inc. (JBIO)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Jade Biosciences, Inc. (JBIO)

Income Statement (Annual)

Income Statement (Annual)